Autologous PRP or "The Fairy Platelet" in the magical land of regenerative autologous cellular medicine. Antoine TURZI. CEO of RegenLab
Platelet Rich Plasma (PRP) has emerged as an innovative therapeutic modality in a variety of medical fields, offering promising prospects for wound healing, facial rejuvenation and even genital rejuvenation.
Our clinical research is resolutely committed to studying these applications, seeking to determine the efficacy and safety of RegenPRP® (standardized PRP prepared with technology from RegenLab SA, Switzerland) in these varied clinical contexts.
THE RISE OF PLATELET-RICH PLASMA (PRP) IN REGENERATIVE MEDICINE: A PROMISING HORIZON. Prof. Jean-Paul MENINGAUD, Scientific Director, L&M.
Editorial 1 THE IMPROVEMENT OF PLATE-RICH PLASMA (PRP) IN REGENERATIVE MEDICINE: A PROMISING HORIZON. Prof. Jean-Paul MENINGAUD Head of the Plastic, Reconstructive and Maxillofacial Surgery Department. Hôpital Henri Mondor, Créteil, France. Scientific Director of "Look et Medecine". President of the "AIME" Congress. Regenerative medicine, in its perpetual quest for progress and innovation, has recently been enriched by a promising approach: the use of platelet-rich plasma (PRP). This [...]
